NCT02222129View on ClinicalTrials.gov

Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Pain, Postoperative
Interventions
DRUG

Bupivacaine

DRUG

liposomal bupivacaine

Trial Locations (2)

78205

Baptist Health System, San Antonio

78229

Methodist Healthcare System, San Antonio

All Listed Sponsors
lead

Knight, Richard, M.D.

INDIV

NCT02222129 - Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery | Biotech Hunter | Biotech Hunter